Literature DB >> 32268087

Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated Tumorigenesis.

Amy I Yu1, Lili Zhao2, Kathryn A Eaton3, Sharon Ho4, Jiachen Chen5, Sara Poe6, James Becker6, Allison Gonzalez4, Delaney McKinstry4, Muneer Hasso4, Jonny Mendoza-Castrejon7, Joel Whitfield8, Charles Koumpouras3, Patrick D Schloss3, Eric C Martens3, Grace Y Chen9.   

Abstract

There is increasing evidence that gut microbiome perturbations, also known as dysbiosis, can influence colorectal cancer development. To understand the mechanisms by which the gut microbiome modulates cancer susceptibility, we examine two wild-type mouse colonies with distinct gut microbial communities that develop significantly different tumor numbers using a mouse model of inflammation-associated tumorigenesis. We demonstrate that adaptive immune cells contribute to the different tumor susceptibilities associated with the two microbial communities. Mice that develop more tumors have increased colon lamina propria CD8+ IFNγ+ T cells before tumorigenesis but reduced CD8+ IFNγ+ T cells in tumors and adjacent tissues compared with mice that develop fewer tumors. Notably, intratumoral T cells in mice that develop more tumors exhibit increased exhaustion. Thus, these studies suggest that microbial dysbiosis can contribute to colon tumor susceptibility by hyperstimulating CD8 T cells to promote chronic inflammation and early T cell exhaustion, which can reduce anti-tumor immunity.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD8 T cells; T cell exhaustion; colitis; colon cancer; inflammation; microbiome

Mesh:

Year:  2020        PMID: 32268087      PMCID: PMC7934571          DOI: 10.1016/j.celrep.2020.03.035

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  88 in total

1.  Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells.

Authors:  J M Curtsinger; C S Schmidt; A Mondino; D C Lins; R M Kedl; M K Jenkins; M F Mescher
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

2.  Human gut microbiome and risk for colorectal cancer.

Authors:  Jiyoung Ahn; Rashmi Sinha; Zhiheng Pei; Christine Dominianni; Jing Wu; Jianxin Shi; James J Goedert; Richard B Hayes; Liying Yang
Journal:  J Natl Cancer Inst       Date:  2013-12-06       Impact factor: 13.506

3.  Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform.

Authors:  James J Kozich; Sarah L Westcott; Nielson T Baxter; Sarah K Highlander; Patrick D Schloss
Journal:  Appl Environ Microbiol       Date:  2013-06-21       Impact factor: 4.792

Review 4.  Role of the microbiota in immunity and inflammation.

Authors:  Yasmine Belkaid; Timothy W Hand
Journal:  Cell       Date:  2014-03-27       Impact factor: 41.582

5.  The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis.

Authors:  Grace Y Chen; Michael H Shaw; Gloria Redondo; Gabriel Núñez
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

6.  IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.

Authors:  Florian R Greten; Lars Eckmann; Tim F Greten; Jin Mo Park; Zhi-Wei Li; Laurence J Egan; Martin F Kagnoff; Michael Karin
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

7.  Global patterns and trends in colorectal cancer incidence and mortality.

Authors:  Melina Arnold; Mónica S Sierra; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  Gut       Date:  2016-01-27       Impact factor: 23.059

8.  Manipulation of the Gut Microbiota Reveals Role in Colon Tumorigenesis.

Authors:  Joseph P Zackular; Nielson T Baxter; Grace Y Chen; Patrick D Schloss
Journal:  mSphere       Date:  2015-11-04       Impact factor: 4.389

9.  Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation.

Authors:  Benoit Chassaing; Gayathri Srinivasan; Maria A Delgado; Andrew N Young; Andrew T Gewirtz; Matam Vijay-Kumar
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

10.  The gut microbiome modulates colon tumorigenesis.

Authors:  Joseph P Zackular; Nielson T Baxter; Kathryn D Iverson; William D Sadler; Joseph F Petrosino; Grace Y Chen; Patrick D Schloss
Journal:  MBio       Date:  2013-11-05       Impact factor: 7.867

View more
  32 in total

1.  Targeting the aryl hydrocarbon receptor in stem cells to improve the use of food as medicine.

Authors:  Huajun Han; Arul Jayaraman; Stephen Safe; Robert S Chapkin
Journal:  Curr Stem Cell Rep       Date:  2021-01-05

2.  Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer.

Authors:  Abigail E Overacre-Delgoffe; Hannah J Bumgarner; Anthony R Cillo; Ansen H P Burr; Justin T Tometich; Amrita Bhattacharjee; Tullia C Bruno; Dario A A Vignali; Timothy W Hand
Journal:  Immunity       Date:  2021-12-02       Impact factor: 31.745

Review 3.  Regulation of tissue-resident memory T cells by the Microbiota.

Authors:  Abigail E Overacre-Delgoffe; Timothy W Hand
Journal:  Mucosal Immunol       Date:  2022-02-22       Impact factor: 8.701

4.  Individuals at risk for rheumatoid arthritis harbor differential intestinal bacteriophage communities with distinct metabolic potential.

Authors:  Mihnea R Mangalea; David Paez-Espino; Kristopher Kieft; Anushila Chatterjee; Meagan E Chriswell; Jennifer A Seifert; Marie L Feser; M Kristen Demoruelle; Alexandra Sakatos; Karthik Anantharaman; Kevin D Deane; Kristine A Kuhn; V Michael Holers; Breck A Duerkop
Journal:  Cell Host Microbe       Date:  2021-05-05       Impact factor: 21.023

5.  Effect of bacterial contamination in bile on pancreatic cancer cell survival.

Authors:  Hannah R Shrader; Ann M Miller; Ann Tomanek-Chalkley; Ashley McCarthy; Kristen L Coleman; Po Hien Ear; Ashutosh K Mangalam; Aliasger K Salem; Carlos H F Chan
Journal:  Surgery       Date:  2020-10-22       Impact factor: 3.982

Review 6.  NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes.

Authors:  Ilona M Gora; Anna Ciechanowska; Piotr Ladyzynski
Journal:  Cells       Date:  2021-02-03       Impact factor: 6.600

7.  Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma.

Authors:  Gongjian Zhu; Haixiang Su; Caroline H Johnson; Sajid A Khan; Harriet Kluger; Lingeng Lu
Journal:  Eur J Cancer       Date:  2021-05-04       Impact factor: 10.002

8.  The Potential of Gut Microbiota Metabolic Capability to Detect Drug Response in Rheumatoid Arthritis Patients.

Authors:  Maozhen Han; Na Zhang; Yujie Mao; Bingbing Huang; Mengfei Ren; Zhangjie Peng; Zipeng Bai; Long Chen; Yan Liu; Shanshan Wang; Shenghai Huang; Zhixiang Cheng
Journal:  Front Microbiol       Date:  2022-04-08       Impact factor: 6.064

9.  Integrated Bioinformatics Analysis Identifies ELAVL1 and APP as Candidate Crucial Genes for Crohn's Disease.

Authors:  Heli Li; Qianru Li; Shiran Sun; Ping Lei; Xiong Cai; Guanxin Shen
Journal:  J Immunol Res       Date:  2020-07-17       Impact factor: 4.818

Review 10.  Mechanisms of PD-L1 Regulation in Malignant and Virus-Infected Cells.

Authors:  Hadia Farrukh; Nader El-Sayes; Karen Mossman
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.